Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 3INDUSTRY 2NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 8Sarcoma 4CNS 4Other hematologic neoplasm 2Lymphoid 2Genitourinary 2Gynecologic 1Endocrine 1Dermatologic 1Classical hematology 1

Conditions

Somatostatinoma 5Kidney Neoplasms 5Adrenocortical Carcinoma 5Insulinoma 4Glucagonoma 4Gastrinoma 4Carcinoma, Islet Cell 4Thyroid Neoplasms 3Thyroid Carcinoma, Anaplastic 3Thyroid Cancer, Papillary 3Squamous Cell Carcinoma of Head and Neck 3Sarcoma 3Salivary Gland Neoplasms 3Pheochromocytoma 3Neuroendocrine Tumors 3Head and Neck Neoplasms 3Carcinoma, Medullary 3Adenocarcinoma, Follicular 3Vipoma 2Sarcoma, Synovial 2Sarcoma, Endometrial Stromal 2Pituitary Neoplasms 2Ovarian Neoplasms 2Neurofibrosarcoma 2Neoplasms 2Neoplasm Metastasis 2Malignant mesenchymal tumor 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2

Interventions

Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Retinoblastoma × Endocrine × Clear all
NCT01048892 2014-01-30

Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features

Children's Oncology Group

Phase 1 Completed
22 enrolled
CNSEndocrineGenitourinaryOther solid neoplasmSarcoma

Kidney Neoplasms, Wilms Tumor, Neuroblastoma, Retinoblastoma, Sarcoma, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡